Publications by authors named "Koji Hanaki"

Claim this Profile
C
Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
Norio Komatsu, Kojo Arita, Hironori Mitsui, Takanori Nemoto, Koji Hanaki

Int J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The effect of ferric citrate hydrate as an iron replacement therapy in Japanese patients with iron deficiency anemia].
Norio Komatsu, Tadao Akizawa, Kojo Arita, Hironori Mitsui, Takanori Nemoto, Koji Hanaki

Rinsho Ketsueki· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
Norio Komatsu, Kojo Arita, Hironori Mitsui, Takanori Nemoto, Koji Hanaki

Int J Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study.
Keitaro Yokoyama, Masafumi Fukagawa, Takashi Akiba, Masaaki Nakayama, Kyoko Ito, Koji Hanaki

Sci Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hepatocarcinogenic tryptophan-pyrolyzate component, Trp-P-1, decreases serum total testosterone level and induces hepatic Cyp1a2 in male mice.
Masakuni Degawa, Koji Hanaki, Masashi Sekimoto

Cancer Sci· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis